SM-88 as Maintenance Therapy for Advanced Ewing's Sarcoma Patients and as Salvage Therapy for Sarcoma Patients
Conditions:   Sarcoma, Ewing;   Sarcoma Intervention:   Drug: Combination metyrosine-derivative, low-dose sirolimus, phenytoin and methoxsalen Sponsors:   Sarcoma Oncology Research Center, LLC;   Joseph Ahmed Foundation;   Tyme, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials